Bavarian Nordic A/S appointed Henrik Juuel as executive vice president and CFO.
Juuel plans to join the Danish company in the fourth quarter of 2018. He is the CFO of Orexo AB (publ), a specialty pharmaceutical company based in Sweden.
Orexo said Juuel's last working day with the company will be in November and it has started the search for a replacement. Juuel has been the CFO of Orexo since 2013.
Denmark-based Bavarian Nordic is a biotechnology company, which develops, manufactures and commercializes a portfolio of novel vaccines for the prevention and treatment of life-threatening infectious diseases and cancer.
